Skip to Content
Merck
All Photos(1)

Key Documents

P-076

Supelco

Propofol solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Sign Into View Organizational & Contract Pricing

Select a Size

1 ML
€135.00

€135.00


Please contact Customer Service for Availability

Request a Bulk Order

Select a Size

Change View
1 ML
€135.00

About This Item

Empirical Formula (Hill Notation):
C12H18O
CAS Number:
Molecular Weight:
178.27
EC Number:
UNSPSC Code:
41116107
NACRES:
NA.24

€135.00


Please contact Customer Service for Availability

Request a Bulk Order

grade

certified reference material

form

liquid

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

1.0 mg/mL in methanol

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

forensics and toxicology

format

single component solution

storage temp.

−20°C

SMILES string

CC(C)c1cccc(C(C)C)c1O

InChI

1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3

InChI key

OLBCVFGFOZPWHH-UHFFFAOYSA-N

General description

Propofol, also known as Diprivan®, is a short-acting, hypnotic drug intravenously administered for the induction and maintenance of general anesthesia and sedation. This certified reference solution is suitable for a variety of uses from forensic and forensic toxicology analysis to drug monitoring in plasma or whole blood.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Diprivan is a registered trademark of Abraxis Bioscience, Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Target Organs

Eyes

Storage Class Code

3 - Flammable liquids

WGK

WGK 2

Flash Point(F)

49.5 °F - closed cup

Flash Point(C)

9.7 °C - closed cup


Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

EU REACH Annex XVII (Restriction List)

CAS No.

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 2

1 of 2

Jeffrey W Sall et al.
Anesthesia and analgesia, 117(1), 65-67 (2013-05-02)
Propofol has been reported to have high stability in glass and relatively high stability up to 24 hours in polyvinyl chloride-based medical plastics. Recent publications have observed the effects of propofol on cells and tissues grown in culture. Many cell
Deepak Gupta et al.
Middle East journal of anaesthesiology, 21(6), 863-867 (2013-05-03)
The concerns for hyperoxia-related brain tissue injury are well known to the medical community. The cerebro-vasodilatory properties of sevoflurane may create relative cerebral tissue "hyperoxia" during inhalational induction as compared to a propofol-based intravenous induction of anesthesia. The objective for
V V Shmelev et al.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 113(4), 30-34 (2013-06-07)
It was studied 238 patients after the reconstructive surgeries of atherosclerotic stenosing lesions of carotid arteries using different types of anesthesia. Neuropsychological testing included MMSE, the Frontal Assessment battery and the Clock drawing test. Regional anesthesia in the combination with
The effective effect-site propofol concentration for induction in morbidly obese patients using total body weight with a new pharmacokinetic model.
Natalia F de la Fuente et al.
Anesthesia and analgesia, 117(1), 283-284 (2013-06-22)
Primum non nocere or how to resolve drug-induced respiratory depression.
Albert Dahan et al.
Anesthesiology, 118(6), 1261-1263 (2013-05-24)

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service